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Background: Hemorrhage is undoubtedly one of the main factors contributing to morbidity and mortality in liver
resections. Vascular occlusion techniques are effective in controlling intraoperative bleeding, but they cause liver
damage due to ischemia. We evaluated the effectiveness and safety of using a combined technique for hepatic
parenchymal transection without liver inflow occlusion.
Methods: Three hundred and thirteen consecutive patients who underwent liver resection in four
hepato-pancreato-biliary units. Hepatic parenchymal transection was carried out using a combined technique of
saline-linked radiofrequency precoagulation and ultrasonic aspiration without liver inflow occlusion.
Results: During the study period 114 minor and 199 major hepatic resections were performed. The mean amount
of intraoperative blood loss was 377 ml (SD 335 ml, range 50 to 2,400 ml) and the blood transfusion rate was
10.5%. The median amount of blood loss during parenchymal transection and parenchymal transection time was
222 ml (SD 224 ml, range 40 to 2,100 ml) and 61 minutes (range 12 to 150 minutes) respectively. There were two
postoperative deaths (0.6%). Complications occurred in 84 patients (26.8%) and most complications were minor.
Conclusions: Combined technique of saline-linked radiofrequency ablation and ultrasonic aspiration for liver
resection is a safe method for both major and minor liver resections. The method is associated with decreased
blood loss, reduced postoperative morbidity, and minimal mortality rates. We believe that this combined technique
is comparable to other techniques and should be considered as an alternative.
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Hepatic resection is widely accepted as the only poten-
tial curative treatment for patients with a wide variety of
liver conditions [1-5]. Hemorrhage is one of the main
factors contributing to morbidity and mortality in major
liver resections [6-11]. However, bleeding and subsequent* Correspondence: kneophy2@gmail.com
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article, unless otherwise stated.blood transfusion may increase the recurrence rate and re-
duce the survival rate for malignant diseases [7,12-14].
The concept of introducing bloodless techniques to fa-
cilitate surgical resection of liver tumors has stimulated
hepatobiliary surgeons to experiment with new proce-
dures. Initial techniques involved clamping of outflow
(total vascular exclusion), and inflow vessels (Pringle man-
euver), aiming to reduce bleeding during parenchymal
transaction [15-17]. The Pringle maneuver, which involves
the control of the hepatic vascular inflow by clamping the
hepatoduodenal ligament, represents the most simple oftral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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represents a valuable tool for managing intraoperative
bleeding, but at the same time places the patient at a high
risk of liver damage due to ischemic reperfusion syndrome
and many other complications [18-24]. Consequently, the
use of liver occlusion has reduced among liver surgeons
but is still used in a few centers. One European survey re-
vealed that 19% of surgeons apply the Pringle maneuver
routinely [25].
The need to avoid the complications related to major
vascular occlusions has resulted in the use of liver paren-
chymal transection without clamping techniques. Paren-
chymal transection tools such as the Cavitron ultrasonic
surgical aspirator (CUSA®), saline-linked radiofrequency
precoagulation, harmonic scalpel, bipolar scissors, Liga-
sure device, hydrodissectors, or monopolar floating ball,
single or in combinations, are commonly used by ex-
perienced surgical teams and the published results are en-
couraging. The combination of new transection tools,
concomitant anesthetic and critical care improvements
have dramatically reduced morbidity and mortality rates.
We report the efficacy and complications of a com-
bined technique for liver resection without liver inflow
occlusion in 313 consecutive patients with primary or
metastatic liver malignancies. This technique uses com-
binational Cavitron ultrasonic surgical aspirator (CUSA;
ValleyLab, Boulder, CO, USA) and a saline-linked radio-
frequency dissecting sealer (Aquamantys®).
Methods
From September 2007, to March 2013, all patients who
underwent liver resection for liver malignancies, with
combined technique using CUSA® and Aquamantys® at
the following 4 hepato-pancreato-biliary (HPB) units: 1)
Department of Academic Surgery, Royal Marsden Hospital,
London, UK, 2) The London Clinic Hospital, London, UK,
3) Nicosia Department of Surgery, Division of HPB
Surgery, Nicosia General Hospital, Nicosia, Cyprus, 4)
First Department of Surgery, University of Athens Medical
School, Laikon Teaching Hospital, Athens, Greece have
been included. During this period, this combined tech-
nique was used by three HPB surgeons (FE, PA, MS).
In accordance with international guidelines, all the pa-
tients underwent the necessary preoperative assessment
of their disease, including spiral computed tomography,
magnetic resonance imaging, and/or positron emission
tomography.
Patient data was collected retrospectively and included
demographic details, histological type and number of
tumors, surgical procedure, overall operating time, par-
enchymal transection time, overall amount of intraopera-
tive blood loss (IBL) and blood loss during parenchymal
transaction (PTBL). Major and critical abnormalities
of preoperative and postoperative liver function tests,intraoperative and postoperative complications, mortality
rate, the length of hospital stay, and outcome were also re-
corded. Post hepatectomy liver failure was defined as the
presence of serum bilirubin >50 μmol/l and prothrombin
index <50% in the fifth postoperative day according to the
‘50-50 criteria’ [26].
The resection time was defined as the time from the
start of CUSA® to the completion of parenchymal tran-
section. The overall blood loss was estimated by weight
of the surgical swabs, the amount of blood in the suction
system and the CUSA® suction container following the
entire hepatectomy. Blood loss during liver parenchyma
transection was recorded in a similar way. Blood was
transfused accordingly to maintain the hematocrit above
28 to 30% perioperatively or if the patient developed he-
modynamic instability as a result of blood loss.
This retrospective analysis of liver resection using a
combination of CUSA® and Aquamantys® devices with-
out the need for the Pringle maneuver focuses on the
following outcomes; intraoperative blood loss , parenchy-
mal transection blood loss, need for packed red blood cell
(PRBC) transfusion, length of liver resection time and
postoperative morbidity and 30-day mortality.
For each participating institution, the study was ap-
proved by the local ethics committee and Institutional
Review Board.
Operative technique
Incisions used were a modified right subcostal (J shape),
bilateral subcostal, or Mercedes-like. Central venous pres-
sure was maintained at a low level (usually below 5 mmHg
during the parenchyma transaction) to avoid backflow
bleeding and to facilitate better liver tissue manipulation.
To obviate air embolism, the hepatic resection was per-
formed with the patient in a 15-degree Trendelenburg
position. Minimum accepted urine output was defined at
25 ml /hour. Blood pressure to achieve these demands
was maintained by either volume or vasopressor drug in-
fusion whenever necessary.
In all cases, after exploration of the abdominal cavity
to exclude extrahepatic or peritoneal disease, operative
ultrasound was used to define the tumor, to exclude pre-
operatively undetected lesions and to mark the plane for
liver parenchymal transection. Subsequently, the liver
was mobilized according to the size and site of the lesion
to be resected.
For major hepatectomies the ipsilateral major hepatic
veins were encircled with vessel loops. Additionally, when
an anatomic resection was planned, hilar dissection was
performed. The ipsilateral branch of the hepatic artery,
portal vein, and common bile duct were encircled but
not divided until the parenchymal dissection reached
that point. Hilar dissection was not performed for non-
anatomical hepatectomy.
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parenchymal dissection the hepatic lobe or segment that
was being resected was gently retracted by the assistant in
order to separate the cut surfaces of the liver for optimal
exposure (open book technique). A second surgeon held
the Aquamantys® for coagulation and hemostasis (Figure 1).
The Aquamantys® system, which is a bipolar sealer, delivers
radiofrequency energy and saline simultaneously to the
surgical field in order to provide hemostasis or sealing
across exposed tissue. The radiofrequency energy heats tis-
sues to around 100°C. As a result of the heat, the collagen
in the blood vessel walls shrinks, causing hemostasis. At
the same time the saline, which is delivered to the surgical
field, prevents charring with eschar formation. The device
was efficient in controlling the small bleeding vessels
within the liver parenchyma. Larger vessels and large intra-
hepatic bile ducts were either ligated or clipped.
For major hepatectomies, the ipsilateral hepatic artery,
portal vein branches and bile duct branches were ligated
intrahepatically during parenchymal transection. In ad-
dition, for major hepatectomies, the major hepatic veins
were either suture-ligated and divided or divided using
endovascular staplers at the end of parenchymal transec-
tion. Drains were placed in all patients.
Statistic analysis
We used SPSS statistical software, version 12 (SPSS Inc,
Chicago, IL, USA), for data analysis. Common statistics
were applied in order to estimate the significance of the
results. Chi-square test, Mann–Whitney non-parametric
test, and the Fischer’s exact test were used as appropriate.
Differences were considered to be significant if P <0.05.
Results
Three hundred and thirteen patients were included in
the series (137 female and 176 males). The median ageFigure 1 Hepatic parenchymal transection using CUSA®
and Aquamantys®.was 62 years (range 31 to 85 years). The median age
among patients who underwent major liver resections (a
resection of 3 segments or more) was 61 years and
among patients undergoing minor liver resections (a re-
section of 2 or fewer segments) was 63 years (P-value
0.29). The majority of the patients (247 patients; 78.9%)
had colorectal liver metastases (CRLM) and the rest had
non-colorectal liver metastases (12 patients; 3.8%),
hepatocellular carcinoma (24 patients; 7.7%), cholangio-
carcinoma (25 patients; 8%), and gallbladder carcinoma
(5 patients; 1.6%). The patient and tumor characteristics
are given in Table 1.
We performed 199 (63.58%) major hepatectomies and
114 (36.42%) minor hepatectomies (Table 2). One hundred
and five (33.5%) hepatectomies were performed at the
Royal Marsden Hospital, 80 (25.6%) at the The London
Clinic Hospital, 48 (15.3%) at the Nicosia General Hospital
and 80 (25.6%) in Laikon Teaching Hospital. The propor-
tion of different tumor types (P <0.001) varied in each of
the 4 HPB units; however the type of operation (major
versus minor liver resection) regarding each tumor type
was the same (P >0.05). Forty-two re-do hepatectomies
were successfully performed (41 of recurrent CRLM and 1
of non-colorectal liver metastases). In addition, 41 of the
patients suffering from CRLM underwent a synchronous
liver resection in combination with colon resection. The
liver lesions per patient rate, was statistically significant
for the patients who underwent major liver resections
compared to the patients who underwent minor liver re-
sections (P-value 0.016) (Table 1).
In Tables 1 and 2, it is clearly demonstrated that for
patients suffering from hepatocellular carcinoma, hilar/
intrahepatic cholangiocarcinoma, and gallbladder car-
cinoma that major hepatectomy as a treatment decision
was more frequent compared to patients suffering from
liver metastasis (96.29 versus 56.75%, P-value <0.001).
When comparing the type and the extent of liver resec-
tion among patients with CRLM with those with non-
colorectal liver metastases it is observed that major
hepatectomies were more frequently performed in the
first group of patients (42.1 versus 25%, P = 0.023).
The overall operative time (mean) was 210 minutes
(minimum 90 minutes, maximum 550 minutes). The mean
parenchymal transection time was 51 minutes (minimum
18 minutes, maximum 120 minutes). The operative time
for parenchymal transection was affected due to the raw
liver surface. Major hepatectomies were prolonged with
mean parenchymal transection time 69 minutes and range
48 to 120 minutes compared to minor liver resections;
mean 29 minutes, range 18 to 52 minutes (P <0.001).
The mean overall intraoperative blood loss was 377 ml
(SD 335 ml, range 50 to 2,400 ml), and the mean blood
loss during parenchymal transection was 223 ml (SD
224 ml, range 40 to 2,100 ml) (Table 3). Amongst the
Table 1 Patient and tumor characteristics
Characteristic Finding P-value
Major Hepatectomya Minor Hepatectomyb Total
Age, mean (SD), (minimum-maximum) years 61 (10.74) (31 to 85) 62.55 (10.20) (37 to 82) 61.57 (10.56) (31 to 85) 0.29
Sex, F/M, n 88/111 49/65 137/176 0.832
Diagnosis, n
Colorectal liver metastases 144 103 247
Non-colorectal liver metastases 3 9 12
Hepatocellular carcinoma 22 2 24
Cholangiocarcinoma 25z 0 25
Gallbladder carcinoma 5 0 5
Total 199 (63.6%) 114 (36.4%) 313
Number of lesions, one/more than one 82/117 63/51 145/168 0.016
athree or more segmentectomies.
btwo or fewer segmentectomies or hepatic wedge resections-tumorectomies.
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parenchymal transection (gender, age, simultaneous pro-
cedures, extent of resection (major versus minor liver re-
section), re-do (second or third) hepatectomy, type of
minor liver resection (anatomic versus non-anatomic
liver resection)), the only factor that actually affected
blood loss during parenchymal transection was the ex-
tent of liver resection (Table 4). In patients undergoing
major hepatectomies, the mean blood loss during paren-
chyma transection was 274 ml (SD 264 ml), while in pa-
tients undergoing minor hepatectomies it was 131 ml
(SD 55.06 ml) (274 ml versus 131 ml P <0.001). Although
the PTBL was greater in non-anatomical liver resection





Major hepatectomy 144 3
Right hepatectomy (with or without
combined wedge resection)
92 1
Left hepatectomy (with or without
combined wedge resection)
36 2
Extended left hepatectomy 4 0
Extended right hepatectomy 12 0
Minor hepatectomy 103 9
Anatomical hepatectomy
Right posterior hepatectomy 9 1




Wedge resections (one or multiple) 35 4145 ml), this difference was not statistically significant
(P = 0.088). Contrary to the PTBL, the IBL was affected
by more factors (Table 4). So, in patients undergoing
major hepatectomies, the IBL was 436 ml, while in pa-
tients undergoing minor hepatectomies it was 273 ml
(P <0.001). Moreover, in patients who underwent re-do
liver resections and in patients who underwent com-
bined colon and hepatic resection the IBL was higher
(539 ml versus 352 ml, P <0.001 and 501 ml versus
358 ml, P = 0.001 respectively).
Thirty-three of our patients (10.5%) underwent blood
transfusion either during the operation or during the
short-term postoperative period. Seventeen of these pa-







22 25 5 199
10 4 0 107
10 3 0 51
0 7 0 11
2 11 5 30
2 0 0 114
0 0 0 10
0 0 0 31
0 0 0 14
2 0 0 20
0 0 0 39
Table 3 Blood loss
Type of operation
Major liver resection (199) Minor liver resection (114) Total (313) P-value
Intraoperative blood loss, mean (SD), (range), ml 436.38 (346.76) 272.72 (286.08) 376.77 (334.92) < 0.001
(100 to 2,400) (50 to 2,360) (50 to 2,400)
Blood loss during parenchymal transection, mean (SD),
(range), ml
273.42 (264) 131.23 (55.06) 221.63 (223.66) < 0.001
(90 to 2,100) (40 to 350) (40 to 2,100)
Blood transfusion, n, (%) 17 (8.5%) 16 (14%) 33 (10.5%) 0.128
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who underwent re-do liver resection or combined colon
and hepatic resection for CRLM, the blood transfusion
rate for the rest of the patients was reduced to 6.7%. This
reduction of blood transfusion rate was predictable as the
mean IBL, when we excluded these patients, decreased
from 377 ml to 336 ml (P <0.001). Most of the transfu-
sions were given during the operation because of heavy
blood loss (up to 2,400 ml). The rest were given in the
postoperative period.
Interestingly, while the IBL in major hepatectomies
was higher than in minor hepatectomies (436 ml versus
273 ml) the blood transfusion rate was higher in minor
liver resections although this difference was not statis-
tically significant (8.5% versus 14%, P = 0.128). As is de-
monstrated in Table 1, within the group of patients with
minor liver resection, the percentage of patients withTable 4 Factors that potentially affect blood loss during pare
intraoperative blood loss
Clinical factor Number Blood loss during parenchyma
transaction mean (SD), ml
Overall 313 221.63 (223.66)
Gender
Female 137 220.8 (206.77)
Male 176 222.27 (236.55)
Age (years)
≤60 138 234 (258.84)
>60 175 211.9 (191.64)
Concomitant procedures
Yes 41 188.78 (75.14)
No 272 226.58 (237.84)
Extent of resection
Major 199 273.42 (264)
Minor 114 131.23 (55.06)
Re-do hepatic resection
Yes 42 247.14 (306.27)
No 271 217.68 (208.43)
Type of minor liver resection
Anatomic 75 123.87 (50.05)
Non-anatomic 39 145.38 (61.85)CRLM was higher than the corresponding one within
the group of patients with major liver resection (103 pa-
tients with CRLM/114 minor liver resections versus 144
patients with CRLM/199 major liver resections P <0.001).
This corresponds to the fact that the highest percentage of
patients within the minor liver resection group had re-
ceived neoadjuvant chemotherapy when compared to the
major liver resection group (92/114 versus 124/199, 80.7%
versus 62.3%, P <0.001). This feature raises the possibility
that the cause for higher transfusion rates in the minor
liver resection group, despite the fact of a lower intraope-
rative blood loss, was the lower preoperative hematocrit
as a result of neoadjuvant chemotherapy.
The length of hospital stay ranged from 3 to 42 days
with a mean value of 6 days.
A total of 119 complications occurred in 84 pa-
tients (26.8%). Complications and their management arenchymal transaction and the overall amount of
P-value Overall amount of intraoperative
blood loss mean (SD), ml
P-value
376.77 (334.92)
0.789 358.91 (294.54) 0.374
390.68 (363.49)
0.366 405.65 (398.17) 0.383
354.01 (274.09)
0.719 500.98 (434.44) 0.001
358.05 (314)
< 0.001 436.38 (346.76) < 0.001
272.72 (286.08)
0.228 539.29 (436.01) < 0.001
351.59 (309.85)
0.088 278 (323.42) 0.56
262.56 (198.78)
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major and minor liver resections revealed no statistical
differences between outcomes (Table 5). According to the
Clavien Classification of Surgical Complications, only 21
patients (6.7%) developed major complications (grade III
and IV). Regarding the 16 patients (5.11%) who developed
a bile leak, 7 of them had a biliary anastomosis in addition
to a liver resection.
Thirty-day mortality was 0.63% (2 deaths during the
postoperative period). One patient died of pulmonary
embolism (PE) caused by deep vein thrombosis (DVT)
on postoperative day two and the other died of liver fail-
ure on postoperative day eight. The first patient, a 78-
year-old obese female, developed DVT and received low
molecular weight heparin subcutaneously. The second
patient underwent extended right hepatectomy for a
Klatskin tumor and developed liver failure immediately
postoperatively.
Discussion
Hemorrhage is one of the main factors contributing to
morbidity and mortality in major liver resections. It is
well known that, in cases of malignant tumors, peri-
operative administration of blood affects not only the
disease-free survival period of the hepatectomized pa-
tient, through modulation of the immune response, but
also the overall survival. An additional source of concern
is the increased risk of infectious disease transmission
through blood transfusion [6-11].Table 5 Postoperative complications and their management
Type of operation
Major liver resection (199) Minor liv
Complications 59 (29.6%) 25 (21.9%
Pleural effusion 23 (11.6%) 10 (8.8%
Bile leak 9 (4.5%) 7 (6.1%)
Wound infection 27 (13.6%) 12 (10.5%
Intraabdominal hemorrhage (minor) 2 (1%) 2 (1.8%)
DVT 4 (2%) 3 (2.6%)
Intraabdominal collection 8 (4%) 6 (5.3%)
Transient hepatic failure 6 (3%) 0 (0%)
Thirty-day mortality 1 (0.5%) 1 (0.9%)
DVT: deep vein thrombosis;
ERCP: endoscopic retrograde cholangiopancreatography;
LMWH: low molecular weight heparin;
PRBC: packed red blood cells;
PTCBD: percutaneous transhepatic biliary drainage.Conversely, the Pringle maneuver represents a valuable
tool for managing intraoperative bleeding but places the
patient at a high risk of liver damage due to ischemic
reperfusion syndrome and other complications, such as
splanchnic congestion and hemodynamic alterations
due to vascular occlusion [18-24]. Intermittent occlu-
sion, hemihepatic vascular occlusion [27], and ischemic
preconditioning of the liver [28] have been used to
minimize liver damage while simultaneously reducing
intraoperative bleeding.
Liver resection using CUSA® and Aquamantys® is
associated with a low transfusion rate and the necessity
for the Pringle maneuver is eliminated
The median blood loss reported from other specialized
centers ranges from 155 ml to more than 750 ml, while
the perioperative blood transfusion range is from 12.6 to
65% [29-35]. Our series has a low intraoperative blood
loss (377 ml) and a low rate of blood transfusions (10.5%)
that are comparable or even lower than the current pub-
lished data from leading liver units as mentioned above
[29-35].
The rate of blood transfusion reduces to 6.7% when
the patients who underwent re-do liver resection or com-
bined colon and hepatic resection for CRLM are excluded.
Higher IBL in this subset of patients is likely to be sec-
ondary to higher blood loss either during difficult liver
mobilization because of previous liver resection or during
colonic resection.Management
er resection (114) Total P-value
) 84 (26.8%) 0.138
) 33 (10.5%) 0.440 28: conservatively
5: drainage
16 (5.1%) 0.532 8: spontaneously resolved
5: ERCP and stenting
3: PTCBD
) 39 (12.5%) 0.433 36: antibiotics
3: debridement
4 (1.3%) 0.624 PRBC transfusion
7 (2.2%) 0.703 7: LMWH
14 (4.5%) 0.609 8: percutaneous drainage
6: conservatively/antibiotics
6 (1.9%) 0.09 Conservatively
2 (0.6%)
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using CUSA® and Aquamantys® is a standardized proced-
ure causing minimal blood loss that removes the dangers
of hepatic inflow occlusion incurred with alternative
techniques such as the Pringle maneuver [20-24].
CUSA® selectively destroys and aspirates parenchyma
leaving vessels and biliary ducts almost intact with larger
vessels and large intrahepatic bile ducts amenable to
ligation or clipping. Aquamantys® delivers radiofrequency
energy and causes protein denaturation. Thus, blood ves-
sel wall collagen is shrunk, resulting in hemostasis. Hence,
Aquamantys® is efficient in controlling the small bleeding
vessels within the liver parenchyma. The combined use of
these two devices allows almost bloodless parenchymal
transection without the need for hepatic inflow occlusion
and ensures an efficient overall operative time (mean par-
enchymal transection time is 51 minutes).
Elimination of the Pringle maneuver allows transection
of the liver without the previous limitation of clamp times.
This results in the opportunity for meticulous parenchy-
mal transection and gives surgical trainees the chance to
develop their skills in this procedure without the previous
time pressures.
This data suggests that liver resection with the use of
the combined technique of saline-linked radiofrequency
ablation and ultrasonic aspiration, is a useful and effi-
cient procedure toward bloodless liver resection without
the use of vascular occlusion and ensures that liver re-
section becomes a comparatively safer procedure.
Liver resection using CUSA® and Aquamantys® is
associated with low postoperative morbidity and
minimum mortality
Although the morbidity rate was 26.8%, it should be noted
that most of these (20.1%) were minor complications.
We performed 199 major hepatectomies from which 41
were extended right or left hepatectomies: 42 of these hep-
atectomies were re-do hepatectomies. By removing the
need for the Pringle maneuver we believe that low postop-
erative liver insufficiency rates (6 patients (1.9%), of which
5 were transient) can be achieved. Furthermore, removal
of the Pringle maneuver eliminates concerns regarding
clamp time. This time comfort in combination with the
use of CUSA® dissection (which leaves biliary ducts intact)
allows meticulous ligation or clipping of large intrahepatic
biliary ducts with small biliary ducts dealt with using the
heating effects of Aquamantys®. The above characteristics
of this combined technique, we believe that is the reason
of the very low rates of bile leak (5.1%) in this series.
A low 30-day mortality rate of 0.63% was achieved in
this consecutive series; this is consistent with rates from
current well-respected centers [29,30,32,36].
Τhe greatest restriction of our study is its retrospective
nature and, as such, a selection bias is a possibility. Thispossibility of selection bias is reduced by the fact that
during the period under study all three surgeons applied
the same surgical technique for liver parenchymal transec-
tion to all of their patients who underwent hepatectomy.
Another restriction of this study is the absence of a com-
parative group. Such a group was not possible as the pre-
viously used techniques for liver parenchymal transection
differed between the participating institutions.
Conclusion
In conclusion, the limitations associated with a retrospec-
tive, single-institution study are acknowledged. However,
the fairly large number of this series allows us to conclude
that combined technique of saline-linked radiofrequency
ablation and ultrasonic aspiration for liver resection is a
safe method for both major and minor liver resections.
The method is associated with decreased blood loss, re-
duced postoperative morbidity, and minimal mortality
rates. We believe that this combined technique is compar-
able to other techniques and should be considered as an
alternative.
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